Table 2.
Variable | Coefficient | Adjusted SHR (95% CI) | P value |
---|---|---|---|
Women | |||
Age, per year | 0.05672 | 1.06 (1.05–1.06) | <0.001 |
Rural residence | 0.18698 | 1.21 (1.10–1.33) | <0.001 |
Hypertension duration, years | |||
No hypertension | Reference | Reference | Reference |
<10 | 0.23651 | 1.27 (1.15–1.39) | <0.001 |
10–20 | 0.38748 | 1.47 (1.34–1.62) | <0.001 |
≥20 | 0.45119 | 1.57 (1.38–1.78) | <0.001 |
Ischemic heart disease | 0.55744 | 1.75 (1.55–1.96) | <0.001 |
Valvular heart disease | 0.6776 | 1.97 (1.50–2.58) | <0.001 |
AF | 0.89362 | 2.44 (2.11–2.83) | <0.001 |
History of cardiac testing | 0.10943 | 1.12 (1.04–1.20) | 0.003 |
COPD or asthma | 0.46512 | 1.59 (1.49–1.70) | <0.001 |
HbA1c, per 1% | 0.09776 | 1.10 (1.09–1.12) | <0.001 |
Hemoglobin, per 1 g/dL | −0.00867 | 0.991 (0.989–0.994) | <0.001 |
GFR, per 1 mL/min/1.73 m2 | −0.01025 | 0.990 (0.988–0.992) | <0.001 |
Alcoholism | 0.84142 | 2.32 (1.44–3.75) | <0.001 |
Mood disorder | 0.5566 | 1.75 (1.31–2.32) | <0.001 |
Men | |||
Age, per year | 0.06 | 1.06 (1.05–1.06) | <0.001 |
Rural residence | 0.14 | 1.15 (1.06–1.24) | <0.001 |
Income quintile | |||
1 (lowest) | Reference | Reference | Reference |
2 | −0.11 | 0.89 (0.83–0.97) | <0.001 |
3 | −0.15 | 0.86 (0.80–0.93) | <0.001 |
4 | −0.23 | 0.79 (0.73–0.86) | <0.001 |
5 (highest) | −0.25 | 0.77 (0.71–0.84) | <0.001 |
Hypertension duration, years | |||
No hypertension | Reference | Reference | Reference |
<10 | 0.22 | 1.24 (1.16–1.34) | <0.001 |
10–20 | 0.44 | 1.55 (1.44–1.67) | <0.001 |
≥20 | 0.48 | 1.62 (1.45–1.81) | <0.001 |
Ischemic heart disease | 0.48 | 1.62 (1.49–1.77) | <0.001 |
Valvular heart disease | 0.69 | 1.99 (1.63–2.44) | <0.001 |
AF | 0.64 | 1.90 (1.68–2.14) | <0.001 |
Previous CABG | −0.31 | 0.73 (0.62–0.87) | <0.001 |
History of cardiac testing | 0.12 | 1.13 (1.06–1.20) | <0.001 |
COPD or asthma | 0.37 | 1.45 (1.37–1.54) | <0.001 |
HbA1c, per 1% | 0.08 | 1.09 (1.07–1.10) | <0.001 |
Hemoglobin, per 1 g/dL | −0.01 | 0.992 (0.990–0.994) | <0.001 |
GFR, per 1 mL/min/1.73 m2 | −0.01 | 0.994 (0.992–0.996) | <0.001 |
Liver disease | 0.50 | 1.65 (1.31–2.09) | <0.001 |
CABG, coronary artery bypass grafting; SHR, subhazard ratio.